Effects of GV1001 on Language Dysfunction in Patients With Moderate-to-Severe Alzheimer's Disease: Post Hoc Analysis of Severe Impairment Battery Subscales.

Dementia and neurocognitive disorders(2023)

引用 0|浏览29
暂无评分
摘要
Patients with moderate-to-severe AD receiving GV1001 had greater language benefits than those receiving placebo, as measured using the SIB language subscale.
更多
查看译文
关键词
alzheimers,language dysfunction,gv1001,impairment,moderate-to-severe
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要